InChI=1S/C27H33N5O5S/c1- 5- 17- 10- 6- 8- 12- 20(17) 29- 23(33) 16- 38- 26(36) 32- 31- 24(34) 22(30- 25(35) 37- 27(2,3) 4) 14- 18- 15- 28- 21- 13- 9- 7- 11- 19(18) 21/h6- 13,15,22,28H,5,14,16H2,1- 4H3,(H,29,33) (H,30,35) (H,31,34) (H,32,36) /t22- /m0/s1 |
OTIWAYTTYNFEKL-QFIPXVFZSA-N |
CCC1=C(NC(=O)CSC(=O)NNC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)OC(C)(C)C)C=CC=C1 |
|
antiplasmodial drug
An antiparasitic drug which is effective against Apicomplexan parasites in the genus Plasmodium. The genus contains over 200 species and includes those responsible for malaria.
cathepsin L (EC 3.4.22.15) inhibitor
An EC 3.4.22.* (cysteine endopeptidase) inhibitor which interferes with the action of cathepsin L (EC 3.4.22.15).
|
|
antiplasmodial drug
An antiparasitic drug which is effective against Apicomplexan parasites in the genus Plasmodium. The genus contains over 200 species and includes those responsible for malaria.
|
|
View more via ChEBI Ontology
S- [2- (2- ethylanilino)- 2- oxoethyl] 2- [(2S)- 2- [(tert- butoxycarbonyl)amino]- 3- (1H- indol- 3- yl)propanoyl]hydrazinecarbothioate
|
N- [(1,1- dimethylethoxy)carbonyl]- L- tryptophan- 2- [[[2- [(2- ethylphenyl)amino]- 2- oxoethyl]thio]carbonyl]hydrazide
|
ChEBI
|
S- [2- (2- ethylanilino)- 2- oxoethyl] 2- [(2S)- 2- [(tert- butoxycarbonyl)amino]- 3- (1H- indol- 3- yl)propanoyl]hydrazine- 1- carbothioate
|
IUPAC
|
SID26681509
|
ChEBI
|
tert- butyl N- [(2S)- 1- [2- [2- (2- ethylanilino)- 2- oxoethyl]sulfanylcarbonylhydrazinyl]- 3- (1H- indol- 3- yl)- 1- oxopropan- 2- yl]carbamate
|
ChEBI
|
958772-66-2
|
CAS Registry Number
|
ChEBI
|
18060772
|
PubMed citation
|
Europe PMC
|
18403718
|
PubMed citation
|
Europe PMC
|
18499453
|
PubMed citation
|
Europe PMC
|
22589721
|
PubMed citation
|
Europe PMC
|
26349060
|
PubMed citation
|
Europe PMC
|
33774649
|
PubMed citation
|
SUBMITTER
|
|